SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 30, 2026

PCSA

Processa Pharmaceuticals, Inc.
BULLISH
Impact 4/10
Horizonweeks Processed5mo ago
Insider cluster: 3 insiders, $0.0M total
Actionable Insight ▲ Bullish

Insider buying by the entire C-suite is a strong signal of near-term confidence. Watch for upcoming clinical trial updates or earnings announcements that may serve as catalysts. Given micro-cap volatility, consider position sizing carefully.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
PCSA ▼ -20.39% at T+60d
LONG call ✗ call lost -20.39% · α vs SPY -21.88% · entry $2.55 → $2.03
Entry = T+0 close
Apr 30, 2026
via day close
T+1d
+5.10%
call +5.10% · α +5.46%
$2.68
settled 6mo ago
T+5d
+7.06%
call +7.06% · α +4.70%
$2.73
settled 6mo ago
T+20d
-0.78%
call -0.78% · α -6.04%
$2.53
settled 5mo ago
T+60d
-20.39%
call -20.39% · α -21.88%
$2.03
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Three C-suite executives at Processa Pharmaceuticals (CEO, CAO, CDO) purchased a combined ~$15.5K of stock on April 30, 2026, all at $2.69 per share. This coordinated insider buying at a micro-cap company signals management confidence, though the total value is modest at ~0.22% of market cap.

Key Financial Metrics

Direction
buying
Total Value
$15.5K
Insiders
3

Key Facts

  • CEO George K. Ng purchased 2,034 shares at $2.69.
  • CAO Wendy Guy purchased 1,748 shares at $2.69.
  • CDO Sian Bigora purchased 1,986 shares at $2.69.
  • Total insider purchases: $15,516.
  • All purchases occurred on the same day, suggesting coordinated confidence.
  • Market cap of PCSA is $7M; purchases represent ~0.22% of shares outstanding.

Financial Impact

$15,516 in insider purchases (0.22% of market cap)

insider ownershipmarket perception

Risk Factors

  • Micro-cap stock with high volatility and low liquidity.
  • Small absolute dollar amount limits signaling power.
  • No disclosed catalyst; buying could be pre-scheduled.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCSA-1777667880481
14 reports for PCSA
Performance horizon
60% Hit rate @ T+5 6 of 10 directional calls Went positive at some point 8 of 10 best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
EFFECT
BEARISH ★ 6/10
$1.81awaiting T+5—$1.79 (+0.83%)
Oct 22, 2026
4d ago
DEF 14A
NEUTRAL ★ 4/10
$1.81awaiting T+5—$1.79 (−0.83%)
Oct 9, 2026
17d ago
S-3
BEARISH ★ 7/10
$1.90 $1.73▲ +8.95%▲ +7.45%$1.79 (+5.53%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$2.03 $2.19▲ +7.88%▲ +2.35%$1.79 (−11.58%)
Jul 1, 2026
16w ago
Insider Cluster
BULLISH ★ 5/10
$2.16 $2.16· 0.00%▼ −1.37%$1.79 (−16.90%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 5/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 1, 2026
21w ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.04▼ −30.31%▼ −27.34%$1.79 (−38.53%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 3h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026